Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
Московский государственный университет им. М.В.Ломоносова, Российское отделение международной научной организации "Кокрановское сотрудничество"
Список исп. литературыСкрыть список 1. Psychotropics 2000/2001 Lundbeck. 2. Krebs MO. Le trouble anxieux: cliniqu et implicacion neurobiologiques. La Revfue des Entretiens de Bichat 2001; 2 (5). 3. Turle G. An investigation into the therapeutic action of hydroxyzine/Atarax in the treatment of nervous disorders and the control of tobacco-habit. Brit J Psychiat 1958; 104: 82 р. 33. 4. Lang L. An evaluation of the efficacy of hydroxyzine (atarax-vistaril) in controlling the behavior of child patients. J-Dent-Child 1965; 32, 4: 253–8) 5. R.Middlefell, K.Edwards Hydroxyzine/Atarax in the relief of tension associated with anxiety neurosis and mild depressive states. Brit J Psychiat 1959; 105: 792–4. 6. Segal L, Tansley A. A clinical trial with Hydroxyzine (Atarax) on a group of maladjusted educationally subnormal children. J Mental-Science; Br J Psychiat from 1963; 1957; 103: 677–81. 7. Rhoades R, Leifer K, Cohan R, Wittig H. Suppression of histamine-induced pruritus by three antihistaminic drugs. J Allergy Clin Immunol,1975 Mar.; 55, 3: 180–5. 8. Kettelhut B, Berkebile C, Bradley D, Metcalfe D. A double-blind, placebo-controlled, crossover trial of ketotifen versus hydroxyzine in the treatment of pediatric mastocytosis. J Allergy Clin Immunol 1989 May; 83, 5: 866–70) 9. Broder L, Lean N, Hilsenbeck S. A randomized blinded clinical trial comparing delta-9-tetrahydrocannabinol (THC) and hydroxizine (HZ) as antiemetics (AE) for cancer chemotherapy (CT). PROC-AM-ASSOC-CANCER-RES; 1982; 23: 514. 10. Vitale M, Fields-Blache C, Luterman. A Severe itching in the patient with burns. J burn care & rehabilitat 1991; 12, 4: 330–3. 11. Kaim S, Klett C, B.Rothfeld. Treatment of the acute alcohol withdrawal state: a comparison of four drugs. Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression, 1968; 9, 2: 305–8. 12. Chignon G. Le trouble Anxiete Generalise: du probleme diagnostique au defi therapeutique. Nervure J psychiat 1988; 11 (suppl.): 1–16. 13. Wittchen H-U, Jakobi F. Size and burden of mental disorders in Europe – a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 2005; 15: 357–76; подробности см. в февральском номере нашего журнала). 14. Goodwin R, Gorman J. Psychopharmakologic Treatment of generalized anxiety disorder and risk of major Depression. Am J Psychiat 2002; 159: 1935–7. 15.Goodwin RD, Jack M. Gorman. Лечение генерализованного тревожного расстройства психотропными препаратами и риск возникновения большого депрессивного расстройства 16. Martin P. Coprescription, Antidepresseurs et anxiolytiques: consequences pratiques de la meilleure connaissance desmecanismes d’action putatifs des anxiolytiques. Actuel Psychiat 2001; 19 (1/2): 2–7. 17. Ferreri M, Hantouche T, M.Billardon. Interet de l’hydroxizyne dans des trouble d’anxiete generalisee: etude controlee en double aveugle versus placebo. L’encephale 1994; 20: 785–91. 18. Llorka P. и др. Efficasy and safety of hydroxisyne in the treatment of generalized anxiety disorder: a 3-month double-blind study. J Clin Psychiatry 2002; 63: 1020–7. 19. Lader Scotto J. A multicenter double-blind comparison of hydroxizine, buspirone and placebo in patient with generalized anxiety disorder. Psychopharmacology 1998; 139: 402–6. 20. De Brabander A, Deberdt W. Effect of hydroxizyne on attentijn and memory. Human Psychopharmacology 1990; 357–62. 21. Samuelian J, Billardon M, Guillou N. Retentissment sur les functions cognitives de deux traitments anxiolitiques chez des patients souffrant d’anxiete generalisee. L’encephale 1995; 21: 147–53.